Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ludwig EnterprisesLUDG EV-to-EBITDA is -15.22 as of Aug. 01, 2026. The stock has 4 warning signs investors should review. Among 510 Medical Devices & Instruments companies, Ludwig Enterprises ranks worse than 196078.24% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ludwig Enterprises's enterprise value is $5.65 Mil.
Ludwig Enterprises's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.37 Mil. Therefore, Ludwig Enterprises's EV-to-EBITDA for today is -15.22.
The historical rank and industry rank for Ludwig Enterprises's EV-to-EBITDA or its related term are showing as below:
LUDG'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -16.16 Med: 0 Max: 0
Current: -15.22
LUDG's EV-to-EBITDA is ranked worse than 100% of 510
companies
in the Medical Devices & Instruments industry
Industry Median: 14.415
vs LUDG: -15.22
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ludwig Enterprises (OTCPK:LUDG) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ludwig Enterprises's PE Ratio (TTM) for today is calculated as:
Ludwig Enterprises's share price for today is $0.0177.
Ludwig Enterprises's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Ludwig Enterprises's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ludwig Enterprises's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ludwig Enterprises EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ludwig Enterprises's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ludwig Enterprises's EV-to-EBITDA falls into.
Ludwig Enterprises's current Enterprise Value is $5.65 Mil.
Ludwig Enterprises's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.37 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ludwig Enterprises (LUDG) has a EV-to-EBITDA of -15.22 as of Aug. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ludwig Enterprises. According to the industry distribution chart, Ludwig Enterprises ranks #999999 out of 510 companies in the Medical Devices & Instruments industry.
Is Ludwig Enterprises' EV-to-EBITDA too high?
Ludwig Enterprises' current EV-to-EBITDA is -15.22. Based on the distribution chart, Ludwig Enterprises ranks #999999 out of 510 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Ludwig Enterprises' EV-to-EBITDA compare to TNON and POAS?
According to the Medical Devices & Instruments industry distribution chart, Ludwig Enterprises ranks #999999 out of 510 companies for EV-to-EBITDA. This places Ludwig Enterprises in the lower half of its industry. The industry median EV-to-EBITDA is 14.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.42, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ludwig Enterprises. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ludwig Enterprises's current EV-to-EBITDA is -15.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ludwig Enterprises stock overvalued right now?
Ludwig Enterprises (LUDG) has a current EV-to-EBITDA of -15.22. The current EV-to-EBITDA is -15.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ludwig Enterprises (LUDG), the current EV-to-EBITDA is -15.22 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ludwig Enterprises Inc is an early-stage genomic technology company focused on developing screening tests for inflammation-related chronic diseases, including cancers. Its platform integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits designed to provide a differentiated and patient-friendly approach to cancer screening. The company's business model combines a business-to-business-to-consumer (B2B2C) approach with partnerships through CLIA-certified laboratories. It is focused on offering home collection kits directly to patients, supported by certified genetic counselors, while also enabling independent laboratories to provide the Revealia Breast test (Ludwig's key product candidate) as a Laboratory Developed Test (LDT).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUDG has been successfully added to your 
